HIPEC addition to SCS did not improve progression-free survival in platinum-sensitive recurrent ovarian cancer patients. Both SCS alone and SCS with HIPEC groups exhibited similar safety profiles, ...
Adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian carcinoma, ...
DETAILS ON THE HIPEC PROCEDURE. PAM PHILLIPS IS GRATEFUL FOR EVERY MINUTE IN 2020 FOR 11 NEWS FIRST CAUGHT UP WITH HER NINE YEARS AGO WHEN SHE WAS A NEW CANCER SURVIVOR IN 2009, SHE WAS DIAGNOSED WITH ...
Tracy Gosson was shocked when she learned in 2019 that she had stage 4 ovarian cancer. With the cancer growing “at a lightning pace,” she underwent her first round of chemotherapy within three weeks ...
SCS combined with HIPEC may improve overall survival in PSROC patients compared to SCS alone, with a statistically significant benefit observed. The risk of severe complications, including anemia and ...
Hyperthermic intraperitoneal chemotherapy (HIPEC) provides an important treatment option that can improve survival for some patients with advanced peritoneal cancer. Managing this disease — and ...
Adding hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C to surgery for locally advanced colorectal cancer (CRC) significantly reduced the risk of locoregional recurrence, the ...
Doctors face big challenges treating rare cancers in the abdomen. They remove tumors, but cancer cells can spread through the abdominal cavity and the surface of other organs, making recurrence a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results